Systematic review and meta-analysis: Efficacy of patented probiotic, VSL#3, in irritable bowel syndrome

Date

2018-12
Language
American English

Embargo Lift Date

Committee Members

Degree

Degree Year

Department

Grantor

Journal Title

Journal ISSN

Volume Title

Found At

Wiley

Abstract

Background: VSL#3 is a patented probiotic for which several clinical trials suggest benefits on motor function, bloating and symptoms of irritable bowel syndrome (IBS).

Objectives: To quantify effects of VSL#3 on abdominal pain, stool consistency, overall response, abdominal bloating, and quality of life (QOL) in IBS through meta-analysis.

Methods: MEDLINE (OvidSP and PubMed), EMBASE, Web of Science, and Scopus were searched up to May 2017. Using a fixed effects model, we pooled data from intention-to-treat analyses of randomized trials (RCTs) comparing VSL#3 to placebo in IBS. Data were reported as relative risk (RR), overall mean difference (MD) or standardized MD (SMD) with 95% confidence intervals (CI). Quality of evidence was rated using the GRADE approach.

Key Results: Among 236 citations, five RCTs (243 patients) were included. No significant differences were observed for abdominal pain (SMD = −0.03; 95% CI −0.29–0.22), bloating (SMD = −0.15; 95% CI −0.40–0.11), proportion of bowel movements with normal consistency (overall MD = 0; 95% CI −0.09–0.08), or IBS-QOL (SMD = 0.08; 95% CI −0.22–0.39). VSL#3 was associated with a nearly statistically significant increase in overall response (RR=1.39; 95% CI 0.99–1.98).

Conclusions & Inferences: In this systematic review and meta-analysis, there was a trend towards improvement in overall response with VSL#3, but no clear evidence effectiveness for IBS. However, the number and sample sizes of the trials are small and the overall quality of evidence for three of the five outcomes was low. Larger trials evaluating validated endpoints in well-defined IBS patients are warranted.

Description

item.page.description.tableofcontents

item.page.relation.haspart

Cite As

Connell, M., Shin, A., James‐Stevenson, T., Xu, H., Imperiale, T. F., & Herron, J. (2018). Systematic review and meta‐analysis: Efficacy of patented probiotic, VSL# 3, in irritable bowel syndrome. Neurogastroenterology & Motility, 30(12), e13427. 10.1111/nmo.13427

ISSN

1365-2982

Publisher

Series/Report

Sponsorship

Major

Extent

Identifier

Relation

Journal

Neurogastroenterology and Motility

Rights

Publisher Policy

Source

PMC

Alternative Title

Type

Article

Number

Volume

Conference Dates

Conference Host

Conference Location

Conference Name

Conference Panel

Conference Secretariat Location

Version

Author's manuscript

Full Text Available at

This item is under embargo {{howLong}}